吉瑞治疗 GYRE
$4.76 +$0.75 (+18.70%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $4.76 0.00%
开盘$4.56
昨收$4.01
当日区间$4.08 – $4.79
成交量359.7K
市值$504.72M
市盈率（TTM）–
股息率–
GYRE 相关新闻
匹配 Gyre Therapeutics 或代码 GYRE 的头条新闻，按最新排序。
- GNI Group: Gyre Therapeutics to Participate in U.S. Healthcare Conferences
- GNI Group: Regarding Gyre Therapeutics' Participation in the U.S. Healthcare Conference
- H.C. Wainwright Sticks to Its Buy Rating for Gyre Therapeutics (GYRE)
- GNI Group: Notice Regarding the Release of Corporate Presentation Materials by Consolidated Subsidiary Gyre Therapeutics, Inc.
- Noble Financial Maintains Gyre Therapeutics(GYRE.US) With Buy Rating, Maintains Target Price $20
- Gyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Epstein David M.
- GNI Group: Notice Regarding the Release of Corporate Presentation Materials by Consolidated Subsidiary Gyre Therapeutics, Inc.
- Gyre Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Sales Results.
- Gyre Therapeutics Q1 Adj. EPS $(0.04) Beats $(0.07) Estimate, Sales $22.519M Miss $31.607M Estimate 中性
- Gyre Therapeutics Q4 Adj. EPS $0.05 Misses $0.06 Estimate, Sales $37.195M Beat $36.303M Estimate 中性
- H.C. Wainwright Maintains Gyre Therapeutics(GYRE.US) With Buy Rating, Maintains Target Price $18
- H.C. Wainwright Initiates Gyre Therapeutics(GYRE.US) With Buy Rating, Announces Target Price $18
- TR | OpenAI - 4o Maintains Gyre Therapeutics(GYRE.US) With Hold Rating, Raises Target Price to $8.5 正面
- H.C. Wainwright Initiates Gyre Therapeutics(GYRE.US) With Buy Rating, Announces Target Price $25
- H.C. Wainwright Initiates a Buy Rating on Gyre Therapeutics (GYRE)
暂无评论——快来第一个聊聊 GYRE。
登录后参与讨论。